Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.94 USD | +3.68% | +21.23% | +6.58% |
Apr. 17 | Sector Update: Health Care Stocks Mixed Wednesday Afternoon | MT |
Apr. 17 | NeuroBo Begins Dosing in Phase 1 Study of Obesity Treatment; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.58% | 18.64M | |
+9.34% | 106B | |
+0.33% | 104B | |
+6.72% | 23.25B | |
-13.47% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-11.84% | 16.99B | |
+8.46% | 14.26B | |
+37.53% | 12.76B |
- Stock Market
- Equities
- NRBO Stock
- News NeuroBo Pharmaceuticals, Inc.
- NeuroBo Pharmaceuticals : HC Wainwright Adjusts Price Target on NeuroBo Pharmaceuticals to $16 From $20, Reiterates Buy Rating